Skip Nav Destination
Issues
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2022, Vol. 45, No. 9
OnkoImmun 17
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (9): I–XII.
https://doi.org/10.1159/000526724
Research Article
A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model
Subject Area:
Oncology
Xue Zhang; Jing-Jing Yuan; Jian-Wu Ding; Shou-Hua Zhang; Zhi-Lin Zhang; Rong-Huan Hu; Dan Gong; Jia-Li Hu; Zi-Wei Tu; Lei Zeng
Oncol Res Treat (2022) 45 (9): 471–479.
https://doi.org/10.1159/000525446
Sociodemographic, Clinical, Lifestyle, and Psychological Correlates of Peripheral Neuropathy among 2- to 12-Year Colorectal Cancer Survivors
Subject Area:
Oncology
Dóra Révész; Cynthia S. Bonhof; Martijn J.L. Bours; Matty P. Weijenberg; Gerard Vreugdenhil; Lonneke V. van de Poll-Franse; Floortje Mols
Oncol Res Treat (2022) 45 (9): 480–493.
https://doi.org/10.1159/000524037
Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort
Subject Area:
Oncology
Annamaria Brioli; Theresa Maria Nägler; Olaposi Yomade; Maria Madeleine Rüthrich; Sebastian Scholl; Jochen J. Frietsch; Inken Hilgendorf; Thomas Ernst; Herbert Gottfried Sayer; Andreas Hochhaus; Lars-Olof Mügge; Marie von Lilienfeld-Toal
Oncol Res Treat (2022) 45 (9): 494–503.
https://doi.org/10.1159/000525493
Systematic Review
A Systematic Review for Evaluation of Specialized Programs for Addressing Young Women with Breast Cancer Problems
Subject Area:
Oncology
Kobra Abedian Kasgri; Morteza Abazari; Hadi Tehrani; Jamshid Yazdani Charati; Safa Momeni Badeleh; Kosar Momeni Badeleh; Mehrsadat Mahdizadeh; Nooshin Peyman
Oncol Res Treat (2022) 45 (9): 504–524.
https://doi.org/10.1159/000525413
Review Article
Established and Experimental Systemic Treatment Options for Advanced Liposarcoma
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (9): 525–543.
https://doi.org/10.1159/000524939
PharmaForum
Behandlung unfitter AML-Patient*innen: Paradigmenwechsel
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (9): 544–545.
https://doi.org/10.1159/000526726
Pharma News
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (9): 546–547.
https://doi.org/10.1159/000526648
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (9): 548–555.
https://doi.org/10.1159/000526727
Society Bulletins
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (9): 556–560.
https://doi.org/10.1159/000526451
